Complement C3
| GO Term |
|---|
| signaling receptor binding |
| C5L2 anaphylatoxin chemotactic receptor binding |
| endopeptidase inhibitor activity |
| receptor ligand activity |
| Position | Description | PubMed ID | GlyTouCan ID | Source |
|---|---|---|---|---|
| 4 |
|
|
||
| 85 | N-linked (GlcNAc...) asparagine |
|
||
| 87 |
|
|
||
| 628 |
|
|
||
| 939 | N-linked (GlcNAc...) asparagine | |||
| 985 |
|
|||
| 1617 | N-linked (GlcNAc...) asparagine | |||
|
|
| Pathway Name | Organism |
|---|---|
| Activation of C3 and C5 | Homo sapiens |
| Alternative complement activation | Homo sapiens |
| G alpha (i) signalling events | Homo sapiens |
| Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell | Homo sapiens |
| Neutrophil degranulation | Homo sapiens |
| Peptide ligand-binding receptors | Homo sapiens |
| Post-translational protein phosphorylation | Homo sapiens |
| Purinergic signaling in leishmaniasis infection | Homo sapiens |
| Regulation of Complement cascade | Homo sapiens |
| Regulation of IGF Activity by IGFBP | Homo sapiens |
Tissue with high expression from Human Protein Atlas. Tissues that are highly expressed are highlighted.
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0060284 | paroxysmal nocturnal hemoglobinuria | |
| DOID:0080301 | atypical hemolytic-uremic syndrome | |
| DOID:0080600 | COVID-19 | |
| DOID:0110019 | age related macular degeneration 7 | |
| DOID:0110021 | age related macular degeneration 9 | |
| DOID:10325 | silicosis | |
| DOID:10652 | Alzheimer's disease | |
| DOID:10873 | Kuhnt-Junius degeneration | |
| DOID:10923 | sickle cell anemia | |
| DOID:2841 | asthma |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.5.0
Last updated: April 6, 2026